Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

Artificial intelligence (AI) transforms oncology by enhancing decision-making, improving patient care, and streamlining ...

The Global AI in Precision Medicine Market is expected to witness a growth rate of 25-30% in the next five ...

Nancy Pelosi’s positions were influenced by broader market volatility, largely tied to uncertainty around trade tariffs.

Tempus AI, Inc. has announced its plan to offer $400 million in convertible senior notes due in 2030 in a private placement, ...

Find the latest Tempus AI, Inc. Class A Common Stock (TEM) annual income statements, balance sheets, financial statements, ratios, and cash flow data at Nasdaq.com.